Display options
Cite
Zeng H, Pang X, Wang S, et al. The preparation of core/shell structured microsphere of multi first-line anti-tuberculosis drugs and evaluation of biological safety. Int J Clin Exp Med. 2015;8(6):8398-414
Zeng, H., Pang, X., Wang, S., Xu, Z., Peng, W., Zhang, P., Zhang, Y., Liu, Z., Luo, C., Wang, X., & Nie, H. (2015). The preparation of core/shell structured microsphere of multi first-line anti-tuberculosis drugs and evaluation of biological safety. International journal of clinical and experimental medicine, 8(6), 8398-414.
Zeng, Hao, et al. "The preparation of core/shell structured microsphere of multi first-line anti-tuberculosis drugs and evaluation of biological safety." International journal of clinical and experimental medicine vol. 8,6 (2015): 8398-414.
Zeng H, Pang X, Wang S, Xu Z, Peng W, Zhang P, Zhang Y, Liu Z, Luo C, Wang X, Nie H. The preparation of core/shell structured microsphere of multi first-line anti-tuberculosis drugs and evaluation of biological safety. Int J Clin Exp Med. 2015 Jun 15;8(6):8398-414. eCollection 2015. PMID: 26309493; PMCID: PMC4538136.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2015 Jun 15;8(6):8398-414. eCollection 2015.

The preparation of core/shell structured microsphere of multi first-line anti-tuberculosis drugs and evaluation of biological safety.

International journal of clinical and experimental medicine

Hao Zeng, Xiaoyang Pang, Shuo Wang, Zhengquan Xu, Wei Peng, Penghui Zhang, Yupeng Zhang, Zheng Liu, Chengke Luo, Xiyang Wang, Hemin Nie

Affiliations

  1. Department of Spine Surgery, The Xiangya Hospital of Central South University 87# Xiangya Road, Changsha 410008, People's Republic of China.
  2. Department of Orthopedics Surgery, The Xiangya Hospital of Central South University 87# Xiangya Road, Changsha 410008, People's Republic of China.
  3. Department of Biomedical Engineering, College of Biology, Hunan University Changsha 410082, People's Republic of China.

PMID: 26309493 PMCID: PMC4538136

Abstract

To introduce a modified method, namely coaxial electrohydrodynamic atomization for the fabrication of distinct core/shell structured microspheres of four first-line ant-tuberculosis drugs with different characteristics in hydrophilic properties in one single step. In group B, we prepared microspheres in which the core and the shell contain hydrophobic and hydrophilic drugs, respectively. In contrast, in group C, the opposite is prepared. The detection of encapsulation efficiency and in vitro release test were performed to confirm the feasibility of the drug-loaded core/shell structured microspheres. Moreover, cell culture experiments and animal experiments have been carried out to evaluate the biological safety of different microspheres in cell growth, cell viability, osteogenesis and migration of BMSCs in vitro and the bone fusion in a bone deficits model in SD rat. Meanwhile, the distribution of drugs and liver and kidney toxicity were monitored. The release patterns of the two groups are significantly different. The release of drugs from Group B microspheres is rather sequential, whereas group C microspheres release drugs in a parallel (co-release) manner. And various concentrations of carrier materials produces core/shell structured microspheres with different appearance. Moreover, the biological safety of core/shell structured microspheres was testified to be satisfactory. These findings present the advantages and possible application of this kind of multi-drug release system in treating skeletal tuberculosis. Moreover, the characteristic sequential release of multi-drugs can be controlled and adjusted based on treatment need and used in treating other disorders.

Keywords: Core/shell structure; ant-tuberculosis drugs; co-release; microspheres; multi drugs

References

  1. Science. 2002 Mar 1;295(5560):1695-8 - PubMed
  2. J Neurooncol. 2005 May;72(3):209-15 - PubMed
  3. J Immunol. 2006 Mar 15;176(6):3707-16 - PubMed
  4. J Control Release. 2008 Aug 7;129(3):207-14 - PubMed
  5. J R Soc Interface. 2009 Mar 6;6(32):271-7 - PubMed
  6. Int Orthop. 2010 Mar;34(3):395-9 - PubMed
  7. Science. 2010 May 14;328(5980):856-61 - PubMed
  8. Biomaterials. 2010 Nov;31(33):8732-40 - PubMed
  9. J Biomed Mater Res A. 2010 Dec 1;95(3):709-16 - PubMed
  10. Cent Eur J Public Health. 2010 Dec;18(4):237 - PubMed
  11. Macromol Rapid Commun. 2011 Nov 1;32(21):1729-34 - PubMed
  12. Int J Nanomedicine. 2012;7:257-70 - PubMed
  13. Small. 2013 Oct 25;9(20):3468-76 - PubMed
  14. Int J Pharm. 2013 Jun 25;450(1-2):235-40 - PubMed
  15. Nat Rev Drug Discov. 2013 May;12(5):388-404 - PubMed
  16. Int J Pharm. 2013 Aug 16;452(1-2):227-32 - PubMed
  17. Adv Colloid Interface Sci. 2014 May;207:178-88 - PubMed
  18. Dalton Trans. 2014 Feb 14;43(6):2588-95 - PubMed
  19. Chem Eng Sci. 2013 Dec 18;104:null - PubMed
  20. J Biomed Mater Res A. 2015 Jan;103(1):252-61 - PubMed
  21. Drug Deliv. 2016;23(3):882-7 - PubMed
  22. J Microencapsul. 2015;32(1):29-39 - PubMed
  23. Int J Pharm. 2014 Dec 10;476(1-2):116-23 - PubMed
  24. Int J Ophthalmol. 2014 Oct 18;7(5):768-72 - PubMed
  25. Eur J Trauma Emerg Surg. 2014 Oct;40(5):607-16 - PubMed

Publication Types